← Eichor
Condition: Hemolysis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hemolysis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel
Phase N/A · 6 location(s) · Genetix Biotherapeutics Inc. · NCT06271512Cord Blood S100B Protein Levels in Neonates Following Intrauterine Transfusions for HDFN-Associated Fetal Anemia
Phase N/A · 1 location(s) · Institute of Mother and Child, Warsaw, Poland · NCT06984445Effect of EMDR for Reduction of Pain Interference in Children With Sickle Cell Disease
NA · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT07001631A Stress and Pain Self-management m-Health App for Adult Outpatients With Sickle Cell Disease
NA · 1 location(s) · University of Florida · NCT04484272Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease
NA · 1 location(s) · Children's National Research Institute · NCT05099874Stroke Prevention in Nigeria 2 Trial
Phase 4 · 2 location(s) · Vanderbilt University Medical Center · NCT06526117UCAR T-cell Therapy Targeting CD19/BCMA in Relapsed/Refractory Autoimmune Hemolytic Anemia
EARLY_Phase 1 · 1 location(s) · The Second Hospital of Anhui Medical University · NCT07530380French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia
Phase N/A · 1 location(s) · University Hospital, Toulouse · NCT02877706Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease
Phase 1/Phase 2 · 10 location(s) · CRISPR Therapeutics AG · NCT07549698Effect of Incentive Respiratory Training on Pulmonary Functions and Functional Capacity in Children With B-thalassemia M
NA · 1 location(s) · Rawan Mohammed Khairy Mostafa Elsawy · NCT07112703Ultrasound Acute Chest Syndrome Sickle Cell Disease
NA · 1 location(s) · Indiana University · NCT06880679AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
Phase 2 · 1 location(s) · Mitchell Cairo · NCT04099966Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
Phase 2 · 1 location(s) · University of California, Davis · NCT06016634A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia [TDT]
EARLY_Phase 1 · 1 location(s) · First Affiliated Hospital of Guangxi Medical University · NCT05762510SCD Stem Cell Mobilization and Apheresis Using Motixafortide
Phase 1 · 3 location(s) · St. Jude Children's Research Hospital · NCT06442761Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders
Phase 2 · 1 location(s) · Mayo Clinic · NCT06333652Promoting Resilience Among Adolescents and Young Adults With Sickle Cell Disease
NA · 1 location(s) · Boston Children's Hospital · NCT06555939Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney Injury
NA · 1 location(s) · University of Colorado, Denver · NCT06349577Safety and Efficacy of RM-004 Cells for Hemoglobin H-Constant Spring Disease
EARLY_Phase 1 · 1 location(s) · The 923rd Hospital of Joint Logistics Support Force of Peopl · NCT06107400Long-term Follow-up Study of BRL-101 for TDT
Phase N/A · 7 location(s) · Bioray Laboratories · NCT06298630Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06147414Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases.
Phase 4 · 4 location(s) · Menzies School of Health Research · NCT07468513Orelabrutinib in the Treatment of Relapsed/Refractory AIHA
Phase 2 · 1 location(s) · Peking Union Medical College Hospital · NCT07453368A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Phase 3 · 105 location(s) · Novo Nordisk A/S · NCT06609226Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT03279094Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
Phase 2 · 1 location(s) · University of Illinois at Chicago · NCT07175051Long-term Safety and Tolerability of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria
Phase 2 · 1 location(s) · Haisco Pharmaceutical Group Co., Ltd. · NCT06745622A Phase Ib, Multicenter, Open-Label Study of Multiple-Dose EA5 in Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Phase 1 · 2 location(s) · Shanghai Lanyi Therapeutics Co., Ltd. · NCT07256301Global PNH Patient Registry
Phase N/A · 1 location(s) · Aplastic Anemia and MDS International Foundation · NCT05755867Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET
Phase 2 · 1 location(s) · St. Jude Children's Research Hospital · NCT05583721
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.